Kempharm Stock Future Price Prediction

KMPH -  USA Stock  

USD 8.88  0.06  0.67%

Kempharm stock price prediction is an act of determining the future value of Kempharm shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Kempharm's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Kempharm and does not consider all of the tangible or intangible factors available from Kempharm's fundamental data. We analyze noise-free headlines and recent hype associated with Kempharm, which may create opportunities for some arbitrage if properly timed.
Please see Kempharm Basic Forecasting Models to cross-verify your projections.

Search Price Prediction 

It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Kempharm based on different types of headlines from major news networks to social media. The Kempharm stock price prediction module provides an analysis of price elasticity to changes in media outlook on Kempharm over a specific investment horizon. Using Kempharm hype-based prediction, you can estimate the value of Kempharm from the perspective of Kempharm response to recently generated media hype and the effects of current headlines on its competitors.
Kempharm Tangible Assets Book Value per Share are most likely to decrease significantly in the upcoming years. The last year's value of Tangible Assets Book Value per Share was reported at 2.82
This module is based on analyzing investor sentiment around taking a position in Kempharm. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Kempharm to buy its stock at a price that has no basis in reality. In that case, they are not buying Kempharm because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Kempharm after-hype prediction price

  $ 8.72  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Kempharm's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Kempharm in the context of predictive analytics.
LowReal ValueHigh
2 Analysts
LowTarget PriceHigh
Estimates (1)
LowProjected EPSHigh
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Kempharm. Your research has to be compared to or analyzed against Kempharm's peers to derive any actionable benefits. When done correctly, Kempharm's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Kempharm.

Kempharm After-Hype Price Prediction Density Analysis

As far as predicting the price of Kempharm at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Kempharm or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many smart people who confused the symmetrical distributions of stock prices, such as prices of Kempharm, with the unreliable approximations that try to describe financial returns.
 Next price density 
      Expected price to next headline 

Kempharm Estimiated After-Hype Price Volatility

In the context of predicting Kempharm's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Kempharm's historical news coverage. Kempharm's after-hype downside and upside margins for the prediction period are 5.65 and 11.79, respectively. We have considered Kempharm's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
17th of September 2021
After-hype Price
Kempharm is somewhat reliable asset. Analysis and calculation of next after-hype price of Kempharm is based on 6 months time horizon.

Kempharm Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Kempharm is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Kempharm backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Kempharm, there might be something going there, and it might present an excellent short sale opportunity.
Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.08  3.68  0.01   0.02  8 Events / Month1 Events / MonthIn about 8 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Kempharm Hype Timeline

Kempharm is now traded for 8.88. The entity has historical hype elasticity of 0.01 and average elasticity to hype of competition of 0.02. Kempharm projected not to react to the next headlinewith price going to stay at about the same level and average media hype impact volatility of over 100%. The immediate return on the next newsis projected to be very small whereas the daily expected return is now at -0.08%. The volatility of relative hype elasticity to Kempharm is about 1362.96%. The volatility of related hype on Kempharm is about 1362.96% with expected price after next announcement by competition of 8.9. About 15.0% of the company outstanding shares are owned by corporate insiders. The book value of Kempharm was now reported as 2.96. The company recorded a loss per share of 6.83. Kempharm had not issued any dividends in recent years. The entity had a split on the 28th of December 2020. Given the investment horizon of 90 days the next projectedpress releasewill be in about 8 days.
Please see Kempharm Basic Forecasting Models to cross-verify your projections.

Kempharm Related Hype Analysis

Having access to credible news sources related to Kempharm's direct competition is more important than ever and may enhance your ability to predict Kempharm's future price movements. Getting to know how Kempharm rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Kempharm may potentially react to the hype associated with one of its peers.
At Risk
Dynavax Technologies 0.27 10 per month 4.89  0.08  7.57 (6.89)  29.94 

Kempharm Additional Predictive Modules

Most predictive techniques to examine Kempharm price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Kempharm using various technical indicators. When you analyze Kempharm charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Kempharm Predictive Indicators

The successful prediction of Kempharm stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Kempharm, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Kempharm based on analysis of Kempharm hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Kempharm's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Kempharm's related companies.

Story Coverage note for Kempharm

The number of cover stories for Kempharm depends on current market conditions and Kempharm's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Kempharm is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Kempharm's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Kempharm Short Properties

Kempharm's future price predictability will typically decrease when Kempharm's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Kempharm often depends not only on the future outlook of the potential Kempharm's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Kempharm's indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out12.45%
Short Percent Of Float12.52%
Float Shares24.56M
Shares Short Prior Month3.21M
Average Daily Volume Last 10 Day338.66k
Average Daily Volume In Three Month735.21k
Date Short Interest28th of May 2021
Please see Kempharm Basic Forecasting Models to cross-verify your projections. Note that the Kempharm information on this page should be used as a complementary analysis to other Kempharm's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Complementary Tools for Kempharm Stock analysis

When running Kempharm price analysis, check to measure Kempharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kempharm is operating at the current time. Most of Kempharm's value examination focuses on studying past and present price action to predict the probability of Kempharm's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Kempharm's price. Additionally, you may evaluate how the addition of Kempharm to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
The market value of Kempharm is measured differently than its book value, which is the value of Kempharm that is recorded on the company's balance sheet. Investors also form their own opinion of Kempharm's value that differs from its market value or its book value, called intrinsic value, which is Kempharm's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kempharm's market value can be influenced by many factors that don't directly affect Kempharm underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kempharm's value and its price as these two are different measures arrived at by different means. Investors typically determine Kempharm value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kempharm's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.